FR11C0037I2 - Antibiotiques macrolides et traitement de la pasteurellose - Google Patents

Antibiotiques macrolides et traitement de la pasteurellose

Info

Publication number
FR11C0037I2
FR11C0037I2 FR11C0037C FR11C0037C FR11C0037I2 FR 11C0037 I2 FR11C0037 I2 FR 11C0037I2 FR 11C0037 C FR11C0037 C FR 11C0037C FR 11C0037 C FR11C0037 C FR 11C0037C FR 11C0037 I2 FR11C0037 I2 FR 11C0037I2
Authority
FR
France
Prior art keywords
pasteurellosis
treatment
derivatives
macrolid antibiotics
macrolid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR11C0037C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zh Biseibutsu Kagaku Ke
Original Assignee
Zh Biseibutsu Kagaku Ke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zh Biseibutsu Kagaku Ke filed Critical Zh Biseibutsu Kagaku Ke
Publication of FR11C0037I1 publication Critical patent/FR11C0037I1/fr
Application granted granted Critical
Publication of FR11C0037I2 publication Critical patent/FR11C0037I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
FR11C0037C 1999-08-30 2011-09-09 Antibiotiques macrolides et traitement de la pasteurellose Active FR11C0037I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24328699 1999-08-30
PCT/JP2000/005721 WO2001016148A1 (fr) 1999-08-30 2000-08-24 Antibiotiques macrolides et traitement de la pasteurellose

Publications (2)

Publication Number Publication Date
FR11C0037I1 FR11C0037I1 (fr) 2011-10-14
FR11C0037I2 true FR11C0037I2 (fr) 2012-06-22

Family

ID=17101600

Family Applications (1)

Application Number Title Priority Date Filing Date
FR11C0037C Active FR11C0037I2 (fr) 1999-08-30 2011-09-09 Antibiotiques macrolides et traitement de la pasteurellose

Country Status (13)

Country Link
US (1) US6514946B1 (fr)
EP (1) EP1216256B1 (fr)
JP (1) JP4573411B2 (fr)
AT (1) ATE261450T1 (fr)
AU (1) AU763732B2 (fr)
BE (1) BE2011C037I2 (fr)
CA (1) CA2391834C (fr)
DE (2) DE122011100013I1 (fr)
DK (1) DK1216256T3 (fr)
ES (1) ES2213597T3 (fr)
FR (1) FR11C0037I2 (fr)
PT (1) PT1216256E (fr)
WO (1) WO2001016148A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006206952B2 (en) * 2005-01-24 2011-08-18 Microbial Chemistry Research Foundation Anti-penicillin resistant pneumococci agent and novel 16-membered ring macrolide derivative
US9148795B2 (en) * 2005-12-22 2015-09-29 Qualcomm Incorporated Methods and apparatus for flexible reporting of control information
NZ574193A (en) * 2006-07-28 2011-09-30 Intervet Int Bv Macrolide synthesis process
CN101506220B (zh) * 2006-07-28 2012-10-17 英特威国际有限公司 大环内酯合成方法
EP2019112A1 (fr) 2007-07-26 2009-01-28 Intervet International BV Formules à l'état solide de macrolide
KR101538599B1 (ko) * 2006-07-28 2015-07-21 인터벳 인터내셔널 비.브이. 마크롤라이드 합성 방법
CN102863487B (zh) * 2012-10-08 2014-11-05 齐鲁动物保健品有限公司 20,23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的制备方法
SI2999707T1 (en) * 2013-05-23 2018-07-31 Bayer Animal Health Gmbh Tylosin derivatives and their preparation process
CN103554203A (zh) * 2013-08-17 2014-02-05 齐鲁动物保健品有限公司 一种泰地罗新无定形晶及其制备方法
CN104788519B (zh) * 2014-01-22 2018-07-20 镇江威特药业有限责任公司 十六元环三胺内酯衍生物及其应用
CN103923141B (zh) * 2014-04-21 2016-04-27 西南大学 一种依托替米考星的合成方法
CN104478974B (zh) * 2014-11-28 2016-08-17 武汉回盛生物科技有限公司 一种20，23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的合成方法
CN104447919B (zh) * 2014-11-28 2017-03-08 武汉回盛生物科技股份有限公司 一种20，23‑二哌啶基‑5‑o‑碳霉胺糖基‑泰乐内酯原料药的精制方法
CN104497082B (zh) * 2015-01-13 2017-12-12 中国兽医药品监察所 一种泰地罗新的合成方法
CN104558076A (zh) * 2015-02-10 2015-04-29 上海皓元化学科技有限公司 一种泰地罗新的制备方法及其中间体化合物
US10287275B2 (en) * 2015-04-16 2019-05-14 Victor Pharma Co., Ltd. Zhenjiang 16-member triamilide derivatives and uses thereof
CN105440093A (zh) * 2015-11-17 2016-03-30 宁夏泰瑞制药股份有限公司 一种泰地罗新的合成方法
CN105919933A (zh) * 2016-06-13 2016-09-07 上海同仁药业股份有限公司 泰地罗新注射液及其制备方法
CN106420600A (zh) * 2016-09-21 2017-02-22 中国水产科学研究院珠江水产研究所 一种替米考星注射用原位凝胶及其制备方法
CN108264530A (zh) * 2016-12-30 2018-07-10 湖北回盛生物科技有限公司 20,23-二卤代-5-o-碳霉胺糖基-泰乐内酯及其合成方法和应用
CN108264529A (zh) * 2016-12-30 2018-07-10 湖北回盛生物科技有限公司 一种20,23-二哌啶-5-o-碳霉胺糖基-泰乐内酯的合成方法
MX2023006349A (es) 2020-12-03 2023-06-12 Intervet Int Bv Un metodo de tratamiento de podredumbre del pie.
CN116731096A (zh) * 2023-06-10 2023-09-12 中国兽医药品监察所 20-醛基-23-哌啶基-5-o-碳霉胺糖基-泰乐内酯及其合成方法及它的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454314A (en) * 1982-08-02 1984-06-12 Pfizer Inc. Antibacterial mycaminosyl tylonolide and related macrolide derivatives
JPS5951299A (ja) * 1982-09-17 1984-03-24 Microbial Chem Res Found ２３−デオキシ−２０−ジヒドロ−マイカミノシルタイロノライド誘導体
JPS59225199A (ja) * 1983-02-10 1984-12-18 Microbial Chem Res Found ２０，２３−ジデオキシ−２３−アルキレンイミノ−２０−置換アミノマイカミノシルレロノライド
US4629786A (en) 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
ZA841277B (en) * 1983-02-28 1985-09-25 Lilly Co Eli C-20-and c-23-modified macrolide derivatives
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
JPS59181299A (ja) * 1983-03-31 1984-10-15 Microbial Chem Res Found ２０，２３−ジデオキシ−２０，２３−ビス置換アミノ−マイカミノシルレロノライド
JPS59227897A (ja) * 1983-06-10 1984-12-21 Microbial Chem Res Found ２０，２３−ジデオキシ−２３−アルキレンイミノ−２０−置換−マイカミノシルレロノライド
US4604380A (en) * 1985-01-18 1986-08-05 Eli Lilly And Company C-23-substituted mycaminosyltylonolide compounds, pharmaceutical compositions and methods of use
TW226373B (fr) * 1992-07-15 1994-07-11 Pfizer

Also Published As

Publication number Publication date
PT1216256E (pt) 2004-07-30
US6514946B1 (en) 2003-02-04
AU6729400A (en) 2001-03-26
JP2001139592A (ja) 2001-05-22
BE2011C037I2 (fr) 2019-10-16
CA2391834C (fr) 2008-08-05
CA2391834A1 (fr) 2001-03-08
DE122011100013I1 (de) 2011-09-15
AU763732B2 (en) 2003-07-31
WO2001016148A1 (fr) 2001-03-08
FR11C0037I1 (fr) 2011-10-14
EP1216256B1 (fr) 2004-03-10
ES2213597T3 (es) 2004-09-01
DK1216256T3 (da) 2004-06-21
DE60008895T2 (de) 2005-01-20
EP1216256A1 (fr) 2002-06-26
ATE261450T1 (de) 2004-03-15
JP4573411B2 (ja) 2010-11-04
DE60008895D1 (de) 2004-04-15

Similar Documents

Publication Publication Date Title
FR11C0037I2 (fr) Antibiotiques macrolides et traitement de la pasteurellose
PE20001112A1 (es) Derivados de quinolina como agentes antibacterianos
DE69330294T2 (de) Inter-hierarchisches Synchronisationssystem und LSI, das dieses System verwendet
DE69625926D1 (de) Absorbierende zusammensetzung und saugfähiges wegwerfkleidungsstück, welches dasselbe enthält
NO991012L (no) 3,6-Ketal- og enoleter-makrolid-antibiotika
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
DE60006823D1 (de) Quinolin-derivate und deren verwendung als antibakterielle wirkstoffe
AU2119200A (en) Medicament
IS2350B (is) 13-atóma asalíð og notkun þeirra sem sýklalyfsmiðlar
FI103704B1 (fi) Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö
DE60331849D1 (de) Antibakterielle wirkstoffe
HUP0004579A2 (hu) Antibakteriális hatású, a 3'-N-pozícióban módosított szerkezetű 6-0-szubsztituált-eritromicin-ketolid-származékok és ezeket tartalmazó gyógyszerkészítmények
FR2667317B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
NO20025134L (no) Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjon hos pattedyr
DE69010924D1 (de) Antibiotikum L53-18A und dessen Herstellung.
TR28331A (tr) 13-ikameli milbemisin türevleri, bunlarin hazirlanmalari ve kullanimlari.
BRPI9703099B8 (pt) derivado de carboidrato, e, composição farmacêutica
FR2666582B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique.
MX9202034A (es) Composicion de derivados de antibioticos de macrolida para el tratamiento o prevencion de mastitis en rumiantes.
DE69004808D1 (de) Antibiotikum N-Acetylbenanomicin B, dessen Herstellung und Verwendung.
TR200103211T2 (tr) Streptococcus pneumoniae enfeksiyonlarının tedavisi.
FR2784379B1 (fr) Derives de quinazolinedione, leurs preparations et leurs applications en therapeutique
ATE222262T1 (de) Antibiotisch wirksame stalobacine
FR2783247B1 (fr) Derives de 2-aminoethyl-quinoleine, leur preparation et leur application en therapeutique
FR2663025B1 (fr) Derives de 2-aminomethylpyrrolidine, leur preparation et leur application en therapeutique.